nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP2C9—Capecitabine—colon cancer	0.0896	0.321	CbGbCtD
Zopiclone—CYP2C8—Fluorouracil—colon cancer	0.0762	0.273	CbGbCtD
Zopiclone—CYP2C9—Fluorouracil—colon cancer	0.0531	0.19	CbGbCtD
Zopiclone—CYP3A4—Irinotecan—colon cancer	0.0322	0.115	CbGbCtD
Zopiclone—CYP3A4—Vincristine—colon cancer	0.0281	0.101	CbGbCtD
Zopiclone—TSPO—blood vessel—colon cancer	0.00187	0.0938	CbGeAlD
Zopiclone—Irritability—Capecitabine—colon cancer	0.00164	0.00234	CcSEcCtD
Zopiclone—Mood swings—Capecitabine—colon cancer	0.00163	0.00233	CcSEcCtD
Zopiclone—Ataxia—Capecitabine—colon cancer	0.00162	0.00231	CcSEcCtD
Zopiclone—Alopecia—Vincristine—colon cancer	0.00161	0.0023	CcSEcCtD
Zopiclone—Dehydration—Capecitabine—colon cancer	0.0016	0.00228	CcSEcCtD
Zopiclone—Chills—Irinotecan—colon cancer	0.0016	0.00228	CcSEcCtD
Zopiclone—Mouth ulceration—Methotrexate—colon cancer	0.0016	0.00228	CcSEcCtD
Zopiclone—Bladder pain—Methotrexate—colon cancer	0.0016	0.00228	CcSEcCtD
Zopiclone—Gynaecomastia—Methotrexate—colon cancer	0.00158	0.00225	CcSEcCtD
Zopiclone—Dry skin—Capecitabine—colon cancer	0.00158	0.00225	CcSEcCtD
Zopiclone—Alopecia—Irinotecan—colon cancer	0.00157	0.00224	CcSEcCtD
Zopiclone—Hypokalaemia—Capecitabine—colon cancer	0.00157	0.00223	CcSEcCtD
Zopiclone—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00155	0.00221	CcSEcCtD
Zopiclone—Back pain—Vincristine—colon cancer	0.00154	0.00219	CcSEcCtD
Zopiclone—Gastritis—Capecitabine—colon cancer	0.00152	0.00217	CcSEcCtD
Zopiclone—Muscular weakness—Capecitabine—colon cancer	0.00152	0.00217	CcSEcCtD
Zopiclone—Alopecia—Fluorouracil—colon cancer	0.00151	0.00215	CcSEcCtD
Zopiclone—Lymphadenopathy—Methotrexate—colon cancer	0.0015	0.00214	CcSEcCtD
Zopiclone—Back pain—Irinotecan—colon cancer	0.0015	0.00214	CcSEcCtD
Zopiclone—Muscle spasms—Irinotecan—colon cancer	0.00149	0.00212	CcSEcCtD
Zopiclone—Asthma—Capecitabine—colon cancer	0.00149	0.00212	CcSEcCtD
Zopiclone—Influenza—Capecitabine—colon cancer	0.00149	0.00212	CcSEcCtD
Zopiclone—Dysphagia—Capecitabine—colon cancer	0.00149	0.00212	CcSEcCtD
Zopiclone—Thrombophlebitis—Methotrexate—colon cancer	0.00148	0.00211	CcSEcCtD
Zopiclone—Anaemia—Vincristine—colon cancer	0.00147	0.0021	CcSEcCtD
Zopiclone—Agitation—Vincristine—colon cancer	0.00146	0.00209	CcSEcCtD
Zopiclone—Photosensitivity—Methotrexate—colon cancer	0.00146	0.00208	CcSEcCtD
Zopiclone—Ill-defined disorder—Irinotecan—colon cancer	0.00144	0.00205	CcSEcCtD
Zopiclone—Anaemia—Irinotecan—colon cancer	0.00143	0.00204	CcSEcCtD
Zopiclone—Bronchitis—Capecitabine—colon cancer	0.00143	0.00204	CcSEcCtD
Zopiclone—Vertigo—Vincristine—colon cancer	0.00143	0.00204	CcSEcCtD
Zopiclone—Vision blurred—Fluorouracil—colon cancer	0.0014	0.00199	CcSEcCtD
Zopiclone—Malaise—Irinotecan—colon cancer	0.0014	0.00199	CcSEcCtD
Zopiclone—Vertigo—Irinotecan—colon cancer	0.00139	0.00199	CcSEcCtD
Zopiclone—Dysuria—Capecitabine—colon cancer	0.00139	0.00198	CcSEcCtD
Zopiclone—Convulsion—Vincristine—colon cancer	0.00138	0.00197	CcSEcCtD
Zopiclone—Hypertension—Vincristine—colon cancer	0.00137	0.00196	CcSEcCtD
Zopiclone—Anaemia—Fluorouracil—colon cancer	0.00137	0.00196	CcSEcCtD
Zopiclone—Photosensitivity reaction—Capecitabine—colon cancer	0.00136	0.00194	CcSEcCtD
Zopiclone—Myalgia—Vincristine—colon cancer	0.00135	0.00193	CcSEcCtD
Zopiclone—Weight increased—Capecitabine—colon cancer	0.00135	0.00193	CcSEcCtD
Zopiclone—Weight decreased—Capecitabine—colon cancer	0.00135	0.00192	CcSEcCtD
Zopiclone—Hypertension—Irinotecan—colon cancer	0.00134	0.00191	CcSEcCtD
Zopiclone—Depression—Capecitabine—colon cancer	0.00132	0.00189	CcSEcCtD
Zopiclone—Discomfort—Irinotecan—colon cancer	0.0013	0.00186	CcSEcCtD
Zopiclone—Neuropathy peripheral—Capecitabine—colon cancer	0.0013	0.00186	CcSEcCtD
Zopiclone—Anaphylactic shock—Vincristine—colon cancer	0.0013	0.00185	CcSEcCtD
Zopiclone—Stomatitis—Capecitabine—colon cancer	0.00129	0.00184	CcSEcCtD
Zopiclone—Infection—Vincristine—colon cancer	0.00129	0.00184	CcSEcCtD
Zopiclone—Urinary tract infection—Capecitabine—colon cancer	0.00129	0.00184	CcSEcCtD
Zopiclone—Conjunctivitis—Capecitabine—colon cancer	0.00129	0.00184	CcSEcCtD
Zopiclone—Convulsion—Fluorouracil—colon cancer	0.00128	0.00183	CcSEcCtD
Zopiclone—Osteoarthritis—Methotrexate—colon cancer	0.00128	0.00183	CcSEcCtD
Zopiclone—Confusional state—Irinotecan—colon cancer	0.00127	0.00182	CcSEcCtD
Zopiclone—Haematuria—Capecitabine—colon cancer	0.00126	0.0018	CcSEcCtD
Zopiclone—Anaphylactic shock—Irinotecan—colon cancer	0.00126	0.0018	CcSEcCtD
Zopiclone—Myalgia—Fluorouracil—colon cancer	0.00126	0.0018	CcSEcCtD
Zopiclone—Chest pain—Fluorouracil—colon cancer	0.00126	0.0018	CcSEcCtD
Zopiclone—Infection—Irinotecan—colon cancer	0.00126	0.00179	CcSEcCtD
Zopiclone—Hyperhidrosis—Vincristine—colon cancer	0.00125	0.00179	CcSEcCtD
Zopiclone—Epistaxis—Capecitabine—colon cancer	0.00125	0.00178	CcSEcCtD
Zopiclone—Discomfort—Fluorouracil—colon cancer	0.00125	0.00178	CcSEcCtD
Zopiclone—Anorexia—Vincristine—colon cancer	0.00124	0.00177	CcSEcCtD
Zopiclone—Irritability—Methotrexate—colon cancer	0.00122	0.00174	CcSEcCtD
Zopiclone—Hyperhidrosis—Irinotecan—colon cancer	0.00122	0.00174	CcSEcCtD
Zopiclone—Confusional state—Fluorouracil—colon cancer	0.00122	0.00174	CcSEcCtD
Zopiclone—Mood swings—Methotrexate—colon cancer	0.00121	0.00173	CcSEcCtD
Zopiclone—Anaphylactic shock—Fluorouracil—colon cancer	0.00121	0.00173	CcSEcCtD
Zopiclone—Anorexia—Irinotecan—colon cancer	0.0012	0.00172	CcSEcCtD
Zopiclone—Ataxia—Methotrexate—colon cancer	0.0012	0.00172	CcSEcCtD
Zopiclone—Infection—Fluorouracil—colon cancer	0.0012	0.00172	CcSEcCtD
Zopiclone—Rhinitis—Capecitabine—colon cancer	0.00119	0.0017	CcSEcCtD
Zopiclone—Hepatitis—Capecitabine—colon cancer	0.00119	0.0017	CcSEcCtD
Zopiclone—Hypoaesthesia—Capecitabine—colon cancer	0.00118	0.00169	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Vincristine—colon cancer	0.00118	0.00169	CcSEcCtD
Zopiclone—Pharyngitis—Capecitabine—colon cancer	0.00118	0.00169	CcSEcCtD
Zopiclone—Tachycardia—Fluorouracil—colon cancer	0.00118	0.00169	CcSEcCtD
Zopiclone—Insomnia—Vincristine—colon cancer	0.00117	0.00167	CcSEcCtD
Zopiclone—Oedema peripheral—Capecitabine—colon cancer	0.00117	0.00167	CcSEcCtD
Zopiclone—Paraesthesia—Vincristine—colon cancer	0.00117	0.00166	CcSEcCtD
Zopiclone—Anorexia—Fluorouracil—colon cancer	0.00115	0.00165	CcSEcCtD
Zopiclone—Insomnia—Irinotecan—colon cancer	0.00114	0.00163	CcSEcCtD
Zopiclone—Paraesthesia—Irinotecan—colon cancer	0.00113	0.00162	CcSEcCtD
Zopiclone—Decreased appetite—Vincristine—colon cancer	0.00113	0.00161	CcSEcCtD
Zopiclone—Dyspnoea—Irinotecan—colon cancer	0.00113	0.00161	CcSEcCtD
Zopiclone—PTGS1—endothelium—colon cancer	0.00113	0.0566	CbGeAlD
Zopiclone—Erythema multiforme—Capecitabine—colon cancer	0.00113	0.00161	CcSEcCtD
Zopiclone—Somnolence—Irinotecan—colon cancer	0.00112	0.0016	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Vincristine—colon cancer	0.00112	0.0016	CcSEcCtD
Zopiclone—Fatigue—Vincristine—colon cancer	0.00112	0.0016	CcSEcCtD
Zopiclone—TSPO—embryo—colon cancer	0.00111	0.0559	CbGeAlD
Zopiclone—Dyspepsia—Irinotecan—colon cancer	0.00111	0.00159	CcSEcCtD
Zopiclone—Tinnitus—Capecitabine—colon cancer	0.00111	0.00158	CcSEcCtD
Zopiclone—Pain—Vincristine—colon cancer	0.00111	0.00158	CcSEcCtD
Zopiclone—Constipation—Vincristine—colon cancer	0.00111	0.00158	CcSEcCtD
Zopiclone—Asthma—Methotrexate—colon cancer	0.00111	0.00158	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0011	0.00157	CcSEcCtD
Zopiclone—Decreased appetite—Irinotecan—colon cancer	0.0011	0.00157	CcSEcCtD
Zopiclone—Insomnia—Fluorouracil—colon cancer	0.00109	0.00156	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Irinotecan—colon cancer	0.00109	0.00156	CcSEcCtD
Zopiclone—Fatigue—Irinotecan—colon cancer	0.00109	0.00155	CcSEcCtD
Zopiclone—Paraesthesia—Fluorouracil—colon cancer	0.00109	0.00155	CcSEcCtD
Zopiclone—Pain—Irinotecan—colon cancer	0.00108	0.00154	CcSEcCtD
Zopiclone—Constipation—Irinotecan—colon cancer	0.00108	0.00154	CcSEcCtD
Zopiclone—Dyspnoea—Fluorouracil—colon cancer	0.00108	0.00154	CcSEcCtD
Zopiclone—Somnolence—Fluorouracil—colon cancer	0.00108	0.00154	CcSEcCtD
Zopiclone—Chills—Capecitabine—colon cancer	0.00107	0.00152	CcSEcCtD
Zopiclone—Dyspepsia—Fluorouracil—colon cancer	0.00107	0.00152	CcSEcCtD
Zopiclone—Gastrointestinal pain—Vincristine—colon cancer	0.00106	0.00151	CcSEcCtD
Zopiclone—Decreased appetite—Fluorouracil—colon cancer	0.00105	0.0015	CcSEcCtD
Zopiclone—Alopecia—Capecitabine—colon cancer	0.00105	0.0015	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00104	0.00149	CcSEcCtD
Zopiclone—Feeling abnormal—Irinotecan—colon cancer	0.00104	0.00149	CcSEcCtD
Zopiclone—PTGS1—blood vessel—colon cancer	0.00104	0.0522	CbGeAlD
Zopiclone—Dysuria—Methotrexate—colon cancer	0.00104	0.00148	CcSEcCtD
Zopiclone—Pain—Fluorouracil—colon cancer	0.00104	0.00148	CcSEcCtD
Zopiclone—Gastrointestinal pain—Irinotecan—colon cancer	0.00103	0.00147	CcSEcCtD
Zopiclone—Abdominal pain—Vincristine—colon cancer	0.00103	0.00146	CcSEcCtD
Zopiclone—Body temperature increased—Vincristine—colon cancer	0.00103	0.00146	CcSEcCtD
Zopiclone—Erectile dysfunction—Methotrexate—colon cancer	0.00102	0.00146	CcSEcCtD
Zopiclone—Dysgeusia—Capecitabine—colon cancer	0.00101	0.00145	CcSEcCtD
Zopiclone—Photosensitivity reaction—Methotrexate—colon cancer	0.00101	0.00144	CcSEcCtD
Zopiclone—Back pain—Capecitabine—colon cancer	0.001	0.00143	CcSEcCtD
Zopiclone—Abdominal pain—Irinotecan—colon cancer	0.000999	0.00143	CcSEcCtD
Zopiclone—Body temperature increased—Irinotecan—colon cancer	0.000999	0.00143	CcSEcCtD
Zopiclone—Feeling abnormal—Fluorouracil—colon cancer	0.000997	0.00142	CcSEcCtD
Zopiclone—Muscle spasms—Capecitabine—colon cancer	0.000996	0.00142	CcSEcCtD
Zopiclone—Drowsiness—Methotrexate—colon cancer	0.000987	0.00141	CcSEcCtD
Zopiclone—Depression—Methotrexate—colon cancer	0.000984	0.0014	CcSEcCtD
Zopiclone—Vision blurred—Capecitabine—colon cancer	0.000977	0.00139	CcSEcCtD
Zopiclone—Tremor—Capecitabine—colon cancer	0.000971	0.00139	CcSEcCtD
Zopiclone—Stomatitis—Methotrexate—colon cancer	0.000962	0.00137	CcSEcCtD
Zopiclone—Ill-defined disorder—Capecitabine—colon cancer	0.000962	0.00137	CcSEcCtD
Zopiclone—Urticaria—Fluorouracil—colon cancer	0.000962	0.00137	CcSEcCtD
Zopiclone—Conjunctivitis—Methotrexate—colon cancer	0.00096	0.00137	CcSEcCtD
Zopiclone—Anaemia—Capecitabine—colon cancer	0.000958	0.00137	CcSEcCtD
Zopiclone—Body temperature increased—Fluorouracil—colon cancer	0.000957	0.00137	CcSEcCtD
Zopiclone—Hypersensitivity—Vincristine—colon cancer	0.000956	0.00136	CcSEcCtD
Zopiclone—Sweating—Methotrexate—colon cancer	0.000946	0.00135	CcSEcCtD
Zopiclone—Haematuria—Methotrexate—colon cancer	0.000941	0.00134	CcSEcCtD
Zopiclone—Malaise—Capecitabine—colon cancer	0.000935	0.00133	CcSEcCtD
Zopiclone—Epistaxis—Methotrexate—colon cancer	0.000931	0.00133	CcSEcCtD
Zopiclone—Vertigo—Capecitabine—colon cancer	0.000931	0.00133	CcSEcCtD
Zopiclone—Hypersensitivity—Irinotecan—colon cancer	0.000931	0.00133	CcSEcCtD
Zopiclone—Asthenia—Vincristine—colon cancer	0.000931	0.00133	CcSEcCtD
Zopiclone—Palpitations—Capecitabine—colon cancer	0.000916	0.00131	CcSEcCtD
Zopiclone—TSPO—epithelium—colon cancer	0.000909	0.0456	CbGeAlD
Zopiclone—Asthenia—Irinotecan—colon cancer	0.000907	0.00129	CcSEcCtD
Zopiclone—Hypertension—Capecitabine—colon cancer	0.000895	0.00128	CcSEcCtD
Zopiclone—Hypersensitivity—Fluorouracil—colon cancer	0.000892	0.00127	CcSEcCtD
Zopiclone—Diarrhoea—Vincristine—colon cancer	0.000888	0.00127	CcSEcCtD
Zopiclone—Hepatitis—Methotrexate—colon cancer	0.000886	0.00126	CcSEcCtD
Zopiclone—Chest pain—Capecitabine—colon cancer	0.000882	0.00126	CcSEcCtD
Zopiclone—Myalgia—Capecitabine—colon cancer	0.000882	0.00126	CcSEcCtD
Zopiclone—Pharyngitis—Methotrexate—colon cancer	0.00088	0.00126	CcSEcCtD
Zopiclone—Anxiety—Capecitabine—colon cancer	0.000879	0.00125	CcSEcCtD
Zopiclone—TSPO—smooth muscle tissue—colon cancer	0.000876	0.044	CbGeAlD
Zopiclone—Discomfort—Capecitabine—colon cancer	0.000872	0.00124	CcSEcCtD
Zopiclone—Diarrhoea—Irinotecan—colon cancer	0.000865	0.00123	CcSEcCtD
Zopiclone—Dry mouth—Capecitabine—colon cancer	0.000863	0.00123	CcSEcCtD
Zopiclone—Dizziness—Vincristine—colon cancer	0.000858	0.00122	CcSEcCtD
Zopiclone—Pruritus—Fluorouracil—colon cancer	0.000856	0.00122	CcSEcCtD
Zopiclone—Confusional state—Capecitabine—colon cancer	0.000853	0.00122	CcSEcCtD
Zopiclone—TSPO—renal system—colon cancer	0.000843	0.0423	CbGeAlD
Zopiclone—Infection—Capecitabine—colon cancer	0.00084	0.0012	CcSEcCtD
Zopiclone—Erythema multiforme—Methotrexate—colon cancer	0.000838	0.0012	CcSEcCtD
Zopiclone—Dizziness—Irinotecan—colon cancer	0.000836	0.00119	CcSEcCtD
Zopiclone—Diarrhoea—Fluorouracil—colon cancer	0.000828	0.00118	CcSEcCtD
Zopiclone—Tinnitus—Methotrexate—colon cancer	0.000826	0.00118	CcSEcCtD
Zopiclone—Tachycardia—Capecitabine—colon cancer	0.000826	0.00118	CcSEcCtD
Zopiclone—Vomiting—Vincristine—colon cancer	0.000825	0.00118	CcSEcCtD
Zopiclone—Rash—Vincristine—colon cancer	0.000818	0.00117	CcSEcCtD
Zopiclone—Hyperhidrosis—Capecitabine—colon cancer	0.000818	0.00117	CcSEcCtD
Zopiclone—Dermatitis—Vincristine—colon cancer	0.000817	0.00117	CcSEcCtD
Zopiclone—Headache—Vincristine—colon cancer	0.000813	0.00116	CcSEcCtD
Zopiclone—Anorexia—Capecitabine—colon cancer	0.000806	0.00115	CcSEcCtD
Zopiclone—Vomiting—Irinotecan—colon cancer	0.000804	0.00115	CcSEcCtD
Zopiclone—Dizziness—Fluorouracil—colon cancer	0.0008	0.00114	CcSEcCtD
Zopiclone—Rash—Irinotecan—colon cancer	0.000797	0.00114	CcSEcCtD
Zopiclone—Dermatitis—Irinotecan—colon cancer	0.000796	0.00114	CcSEcCtD
Zopiclone—Chills—Methotrexate—colon cancer	0.000795	0.00113	CcSEcCtD
Zopiclone—Headache—Irinotecan—colon cancer	0.000792	0.00113	CcSEcCtD
Zopiclone—Alopecia—Methotrexate—colon cancer	0.000783	0.00112	CcSEcCtD
Zopiclone—Nausea—Vincristine—colon cancer	0.000771	0.0011	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000771	0.0011	CcSEcCtD
Zopiclone—Vomiting—Fluorouracil—colon cancer	0.00077	0.0011	CcSEcCtD
Zopiclone—Insomnia—Capecitabine—colon cancer	0.000765	0.00109	CcSEcCtD
Zopiclone—Rash—Fluorouracil—colon cancer	0.000763	0.00109	CcSEcCtD
Zopiclone—Dermatitis—Fluorouracil—colon cancer	0.000762	0.00109	CcSEcCtD
Zopiclone—Paraesthesia—Capecitabine—colon cancer	0.00076	0.00108	CcSEcCtD
Zopiclone—Headache—Fluorouracil—colon cancer	0.000758	0.00108	CcSEcCtD
Zopiclone—Dysgeusia—Methotrexate—colon cancer	0.000756	0.00108	CcSEcCtD
Zopiclone—Dyspnoea—Capecitabine—colon cancer	0.000754	0.00108	CcSEcCtD
Zopiclone—Nausea—Irinotecan—colon cancer	0.000751	0.00107	CcSEcCtD
Zopiclone—Back pain—Methotrexate—colon cancer	0.000746	0.00106	CcSEcCtD
Zopiclone—Dyspepsia—Capecitabine—colon cancer	0.000745	0.00106	CcSEcCtD
Zopiclone—Decreased appetite—Capecitabine—colon cancer	0.000735	0.00105	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Capecitabine—colon cancer	0.00073	0.00104	CcSEcCtD
Zopiclone—Fatigue—Capecitabine—colon cancer	0.000729	0.00104	CcSEcCtD
Zopiclone—Vision blurred—Methotrexate—colon cancer	0.000727	0.00104	CcSEcCtD
Zopiclone—Pain—Capecitabine—colon cancer	0.000723	0.00103	CcSEcCtD
Zopiclone—Constipation—Capecitabine—colon cancer	0.000723	0.00103	CcSEcCtD
Zopiclone—Nausea—Fluorouracil—colon cancer	0.000719	0.00103	CcSEcCtD
Zopiclone—Ill-defined disorder—Methotrexate—colon cancer	0.000716	0.00102	CcSEcCtD
Zopiclone—Anaemia—Methotrexate—colon cancer	0.000713	0.00102	CcSEcCtD
Zopiclone—TSPO—lymphoid tissue—colon cancer	0.0007	0.0351	CbGeAlD
Zopiclone—Feeling abnormal—Capecitabine—colon cancer	0.000697	0.000995	CcSEcCtD
Zopiclone—Malaise—Methotrexate—colon cancer	0.000696	0.000993	CcSEcCtD
Zopiclone—Vertigo—Methotrexate—colon cancer	0.000693	0.000989	CcSEcCtD
Zopiclone—Gastrointestinal pain—Capecitabine—colon cancer	0.000692	0.000987	CcSEcCtD
Zopiclone—TSPO—digestive system—colon cancer	0.000691	0.0347	CbGeAlD
Zopiclone—Urticaria—Capecitabine—colon cancer	0.000672	0.000959	CcSEcCtD
Zopiclone—Abdominal pain—Capecitabine—colon cancer	0.000669	0.000954	CcSEcCtD
Zopiclone—Body temperature increased—Capecitabine—colon cancer	0.000669	0.000954	CcSEcCtD
Zopiclone—Convulsion—Methotrexate—colon cancer	0.000668	0.000954	CcSEcCtD
Zopiclone—GABRA2—vagina—colon cancer	0.00066	0.0331	CbGeAlD
Zopiclone—Chest pain—Methotrexate—colon cancer	0.000657	0.000937	CcSEcCtD
Zopiclone—Myalgia—Methotrexate—colon cancer	0.000657	0.000937	CcSEcCtD
Zopiclone—Discomfort—Methotrexate—colon cancer	0.000649	0.000926	CcSEcCtD
Zopiclone—TSPO—bone marrow—colon cancer	0.000637	0.032	CbGeAlD
Zopiclone—Confusional state—Methotrexate—colon cancer	0.000635	0.000906	CcSEcCtD
Zopiclone—Anaphylactic shock—Methotrexate—colon cancer	0.00063	0.000898	CcSEcCtD
Zopiclone—Infection—Methotrexate—colon cancer	0.000626	0.000893	CcSEcCtD
Zopiclone—Hypersensitivity—Capecitabine—colon cancer	0.000623	0.000889	CcSEcCtD
Zopiclone—TSPO—vagina—colon cancer	0.000611	0.0307	CbGeAlD
Zopiclone—Hyperhidrosis—Methotrexate—colon cancer	0.000609	0.000869	CcSEcCtD
Zopiclone—Asthenia—Capecitabine—colon cancer	0.000607	0.000866	CcSEcCtD
Zopiclone—Anorexia—Methotrexate—colon cancer	0.0006	0.000856	CcSEcCtD
Zopiclone—Pruritus—Capecitabine—colon cancer	0.000598	0.000854	CcSEcCtD
Zopiclone—Diarrhoea—Capecitabine—colon cancer	0.000579	0.000826	CcSEcCtD
Zopiclone—CYP2C8—renal system—colon cancer	0.000578	0.029	CbGeAlD
Zopiclone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000574	0.000819	CcSEcCtD
Zopiclone—Insomnia—Methotrexate—colon cancer	0.000569	0.000813	CcSEcCtD
Zopiclone—Paraesthesia—Methotrexate—colon cancer	0.000565	0.000807	CcSEcCtD
Zopiclone—Dyspnoea—Methotrexate—colon cancer	0.000561	0.000801	CcSEcCtD
Zopiclone—Somnolence—Methotrexate—colon cancer	0.00056	0.000799	CcSEcCtD
Zopiclone—Dizziness—Capecitabine—colon cancer	0.000559	0.000798	CcSEcCtD
Zopiclone—Dyspepsia—Methotrexate—colon cancer	0.000554	0.000791	CcSEcCtD
Zopiclone—Decreased appetite—Methotrexate—colon cancer	0.000547	0.000781	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000544	0.000776	CcSEcCtD
Zopiclone—Fatigue—Methotrexate—colon cancer	0.000543	0.000775	CcSEcCtD
Zopiclone—Pain—Methotrexate—colon cancer	0.000538	0.000768	CcSEcCtD
Zopiclone—Vomiting—Capecitabine—colon cancer	0.000538	0.000767	CcSEcCtD
Zopiclone—Rash—Capecitabine—colon cancer	0.000533	0.000761	CcSEcCtD
Zopiclone—Dermatitis—Capecitabine—colon cancer	0.000533	0.00076	CcSEcCtD
Zopiclone—Headache—Capecitabine—colon cancer	0.00053	0.000756	CcSEcCtD
Zopiclone—Feeling abnormal—Methotrexate—colon cancer	0.000519	0.00074	CcSEcCtD
Zopiclone—TSPO—liver—colon cancer	0.000515	0.0259	CbGeAlD
Zopiclone—Gastrointestinal pain—Methotrexate—colon cancer	0.000515	0.000735	CcSEcCtD
Zopiclone—PTGS1—epithelium—colon cancer	0.000506	0.0254	CbGeAlD
Zopiclone—Nausea—Capecitabine—colon cancer	0.000502	0.000717	CcSEcCtD
Zopiclone—Urticaria—Methotrexate—colon cancer	0.0005	0.000714	CcSEcCtD
Zopiclone—Body temperature increased—Methotrexate—colon cancer	0.000498	0.00071	CcSEcCtD
Zopiclone—Abdominal pain—Methotrexate—colon cancer	0.000498	0.00071	CcSEcCtD
Zopiclone—PTGS1—smooth muscle tissue—colon cancer	0.000487	0.0245	CbGeAlD
Zopiclone—CYP2E1—renal system—colon cancer	0.000487	0.0245	CbGeAlD
Zopiclone—PTGS1—renal system—colon cancer	0.000469	0.0236	CbGeAlD
Zopiclone—GABRB3—liver—colon cancer	0.000468	0.0235	CbGeAlD
Zopiclone—Hypersensitivity—Methotrexate—colon cancer	0.000464	0.000662	CcSEcCtD
Zopiclone—Asthenia—Methotrexate—colon cancer	0.000452	0.000645	CcSEcCtD
Zopiclone—Pruritus—Methotrexate—colon cancer	0.000445	0.000636	CcSEcCtD
Zopiclone—Diarrhoea—Methotrexate—colon cancer	0.000431	0.000615	CcSEcCtD
Zopiclone—GABRA2—lymph node—colon cancer	0.000427	0.0214	CbGeAlD
Zopiclone—CYP2C9—digestive system—colon cancer	0.000421	0.0212	CbGeAlD
Zopiclone—CYP2C8—vagina—colon cancer	0.000419	0.021	CbGeAlD
Zopiclone—Dizziness—Methotrexate—colon cancer	0.000416	0.000594	CcSEcCtD
Zopiclone—CYP2E1—lymphoid tissue—colon cancer	0.000404	0.0203	CbGeAlD
Zopiclone—Vomiting—Methotrexate—colon cancer	0.0004	0.000571	CcSEcCtD
Zopiclone—CYP2E1—digestive system—colon cancer	0.000399	0.0201	CbGeAlD
Zopiclone—Rash—Methotrexate—colon cancer	0.000397	0.000567	CcSEcCtD
Zopiclone—Dermatitis—Methotrexate—colon cancer	0.000397	0.000566	CcSEcCtD
Zopiclone—TSPO—lymph node—colon cancer	0.000395	0.0198	CbGeAlD
Zopiclone—Headache—Methotrexate—colon cancer	0.000394	0.000563	CcSEcCtD
Zopiclone—CYP3A4—renal system—colon cancer	0.000392	0.0197	CbGeAlD
Zopiclone—PTGS1—digestive system—colon cancer	0.000385	0.0193	CbGeAlD
Zopiclone—Nausea—Methotrexate—colon cancer	0.000374	0.000534	CcSEcCtD
Zopiclone—CYP2C8—liver—colon cancer	0.000353	0.0177	CbGeAlD
Zopiclone—PTGS1—vagina—colon cancer	0.00034	0.0171	CbGeAlD
Zopiclone—CYP3A4—digestive system—colon cancer	0.000321	0.0161	CbGeAlD
Zopiclone—CYP2C9—liver—colon cancer	0.000314	0.0158	CbGeAlD
Zopiclone—CYP2E1—liver—colon cancer	0.000298	0.0149	CbGeAlD
Zopiclone—CYP3A4—liver—colon cancer	0.000239	0.012	CbGeAlD
Zopiclone—PTGS1—lymph node—colon cancer	0.00022	0.011	CbGeAlD
